RxDoctor Payments Data

Obie McNair, MD

Internal Medicine · Jackson, MSNPI 1851321384

Payments from drug & device makers

$4,289in general payments, 2019–2025

Across 46 payments — averaging $93.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$3K
  • GSK$651
  • AstraZeneca$244
  • Sanofi-aventis U.S. LLC$183
  • Gilead$110
  • Amarin Pharma, Inc.$106
  • plus $307 from 7 others

What the payments were for

  • Consulting fees$2,68863%
  • Food & beverage$1,60237%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,289 in reported general payments places this provider in the 85th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$472
Medicare patients
36
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban126$95,616
JardianceEmpagliflozin106$78,649
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$20,368
OxycontinOxycodone Hcl15$19,695
EntrestoSacubitril/Valsartan15$16,406
OzempicSemaglutide17$16,110
TrulicityDulaglutide11$12,351
MyrbetriqMirabegron14$11,222
SymbicortBudesonide/Formoterol Fumarate30$9,504
BrilintaTicagrelor18$8,891
XareltoRivaroxaban11$8,185
Tresiba Flextouch U-100Insulin Degludec13$6,650
Spiriva HandihalerTiotropium Bromide13$6,480
Albuterol Sulfate HfaAlbuterol Sulfate206$5,946
TrintellixVortioxetine Hydrobromide23$5,551

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$58$97,045137 claims
AstraZenecaBreztri Aerosphere, Symbicort, Brilinta$244$38,76378 claims
Novo NordiskOzempic, Levemir$94$17,71130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →